From L-R: acting Chief of Staff Lowell Zeta, acting CBER chief Karim Mikhail, acting CDER director Michael Davis and BIO CEO John Crowley (courtesy BIO)

June 24, 2026 02:43 PM EDT

New FDA lead­er­ship strikes con­cil­ia­to­ry note on rare dis­eases, staff morale

Af­ter a year of dis­rup­tions and in­dus­try con­ster­na­tion, a trio of cur­rent FDA lead­ers tried to turn over a new leaf both in the agency’s …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.